
Is In Beating Cells a Hit or Flop? Official Box Office Record & Profit Analysis
The official verdict is out. With a worldwide gross of $30,000,000.00, In Beating Cells is declared a Disaster.
📊 Box Office Snapshot
📔 Detailed Verdict Analysis
📜 Detailed Financial Report
In the competitive landscape of 2017, In Beating Cells debuted as a Drama film with significant commercial expectations. The production path for this project involved significant capital, with a reported budget of approximately $50,000,000.00. In the modern film economy, recovering such an investment requires a multifaceted theatrical strategy spanning domestic and international territories.
📈 Collection Trajectory
The box office journey for In Beating Cells has culminated in a worldwide gross of approximately $30,000,000.00. This figure represents the total theatrical footprint, reflecting a Return on Investment (ROI) of -40%. The underwhelming numbers suggest a disconnect with the intended audience, limiting the film's potential for a long theatrical life.
⚖️ Profitability & Verdict
Analyzing the multiplier effect and market sentiment, In Beating Cells navigated the competitive landscape with an audience reception score of 1/10. When weighing the production costs against the global returns, In Beating Cells is effectively categorized as a Disaster. It serves as an analytical benchmark for the complexities of modern theatrical distribution and evolving viewer preferences.
🔍 Comparables
In the context of other Drama releases, the performance of In Beating Cells will likely influence how studios approach similar projects in the future. Whether through its innovative visual style or its narrative choices, the film's financial footprint remains a key piece of the 2017 box office narrative.